Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses.
about
Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospitalAnticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attackManagement of intraventricular hemorrhageWarfarin reversalEvolving management of symptomatic chronic subdural hematoma: experience of a single institution and review of the literatureClinical utility of rivaroxaban in stroke prevention associated with nonvalvular atrial fibrillation - patient considerationsDeveloping an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making.Modeling intracerebral hemorrhage growth and response to anticoagulationThe critical care management of spontaneous intracranial hemorrhage: a contemporary reviewNon-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation and Associated Intracranial Hemorrhage: A Focused ReviewImportance of risk communication and decision making in cardiovascular conditions in older patients: a discussion paperIntracerebral haemorrhage: an often neglected medical emergencyEmergency case. Head injury in patients using warfarinThe risks of minor head injury in the warfarinised patient.Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage riskAnticoagulation for Atrial Fibrillation in Patients with Cerebral Microbleeds.Intracranial hemorrhage sparing meningioma in an anticoagulated patient.Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: a Danish population-based case-control study.Minor head trauma in anticoagulated patients.Outcome of intracerebral hemorrhage associated with different oral anticoagulants.An integrated epidemiological and neural net model of the warfarin effect in managed care patients.Management of anticoagulant-related intracranial hemorrhage: an evidence-based review.Intracerebral haemorrhages and oral anticoagulation in the north of Scotland.Course, management and outcome of oral-anticoagulant-related intracranial haemorrhages.The management of coumarin-induced over-anticoagulation Annotation.Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case-control study.Physician's fear of anticoagulant therapy in nonvalvular atrial fibrillation.Moving the tipping point: the decision to anticoagulate patients with atrial fibrillationThe challenge of managing fusiform basilar artery aneurysms: from acute ischemic stroke to a massive subarachnoid hemorrhage.Pituitary apoplexy presenting as Addisonian crisis after coronary artery bypass grafting.Antiplatelet/anticoagulant agents and chronic subdural hematoma in the elderlyUse of Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal before Surgical Treatment of Intracranial Hemorrhage.Routine repeat head CT may not be indicated in patients on anticoagulant/antiplatelet therapy following mild traumatic brain injuryPerioperative stroke: evaluation, management, and possible preventive measures.Statin use following intracerebral hemorrhage: a decision analysis.Brain magnetic resonance immediately before surgery in single ventricles and surgical postponement.Incidence of intracerebral and subarachnoid haemorrhage in southern Sweden.Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trialStroke prevention in atrial fibrillation: warfarin faces its challengers.Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populations.
P2860
Q21195016-6BACF1FF-0A32-43CF-88AF-52059D2D12FFQ24241777-9005F868-C6F0-4126-B72B-692CE91FF02EQ24632452-90B6F360-12CA-49C3-AA09-7C7EFB47244CQ24672566-5B481A32-54F1-4B2D-AA5D-192A674DA1E4Q26862513-703AAF96-24B6-4E20-A140-CD5FBC84A791Q27000967-B9E000C4-85A3-47C6-933A-18E345075353Q27321275-C8348B6D-2FD4-4129-BC1B-50B6D7117E54Q27342135-B7D9EEC4-7101-4A75-81F5-E525B1956EEFQ28067962-EBF3719B-4C66-42E2-82F2-E606E25DB67FQ28081918-9F29F0EA-D2A1-46F8-95BA-81C73C2FD4BDQ28188630-FBD6BDA5-D73C-412B-832B-11140227DE91Q28212587-1E70A07A-FF32-4E14-97E8-45854B61B316Q28364470-CF5900B3-D009-492E-97EC-1C2E2B0D7370Q28379585-57182E03-C400-4E06-A3DC-8E0C7D9D5C7EQ30570918-66DB5FBB-E54D-4CEC-AB43-7CE656DA61C3Q30975560-41325449-BC1B-4C0C-9E95-FCFB3B5D179AQ33289802-02FED5D4-BDE8-4B24-B7EC-2C07179C8D52Q33337507-952AF632-47A8-4C07-B331-1F4EFEA9C4AFQ33537542-684B1964-96D2-46E1-B1F6-53824D72EF60Q33617298-5793E6D5-8C77-43DE-8601-46E1EB602E48Q33719250-CCB962CB-03AD-4274-9808-91CF4C55EA04Q33750215-D03C3AF4-3856-4837-99D5-E5222B9DBD52Q34075223-2E24B1B5-E07B-47A6-9C05-D2045FE97615Q34075227-552B8584-B619-4A1F-8F99-513E3CA54D36Q34351118-3B4C6E99-5554-4274-97BE-405E84BE1FCAQ34513276-6D4A139A-8632-460B-BEE8-76A27B368864Q34551073-5D1CC01F-0F79-4D38-939C-A361EC9C587BQ34677974-34FA5285-4770-4AD4-B5FB-08A1C98E1F09Q34769404-C854ACB6-B4A6-4CAE-A4AE-45FFE01A5E47Q34841121-C9B8D3B9-2BC1-4026-B9DC-6E3A5CCB7F16Q34850774-1D54C920-3123-4DFA-93FA-D8702D0A3EF9Q34986856-C83119CD-6652-43A4-A57D-9482FD58400CQ35017948-8A2B753D-68FB-4351-A573-D0CCF61D38AEQ35036027-53E2417D-82D5-4BA2-A87B-DCDDC3B9517DQ35170660-A758D658-DC1C-40F8-9C0E-3C73AF036DECQ35230915-04D25F05-8E30-4DB5-9D5E-CD97C0FDCE67Q35572139-32D3EF1C-BE98-4A55-85AF-979210920544Q35654467-A6216800-3F97-48B2-8E2F-2BF4B5448C44Q35989632-903696A9-D704-4286-80A8-AA5020EEA387Q36075301-313DF2E8-408A-4C64-A3CA-EEAF25F5292D
P2860
Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses.
@en
type
label
Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses.
@en
prefLabel
Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses.
@en
P2093
P356
P1433
P1476
Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses.
@en
P2093
P304
P356
10.1161/01.STR.26.8.1471
P407
P577
1995-08-01T00:00:00Z